loading...| Preferred Name |
amitriptyline hydrochloride |
|
| Synonyms |
|
|
| Definitions |
The hydrochloride salt of the tricyclic dibenzocycloheptadiene amitriptyline with antidepressant and antinociceptive activities. Amitriptyline inhibits the re-uptake of norepinephrine and serotonin by the presynaptic neuronal membrane in the central nervous system (CNS), thereby increasing the synaptic concentration of norepinephrine and serotonin. Due to constant stimulation to these receptors, amitriptyline may produce a downregulation of adrenergic and serotonin receptors, which may contribute to the antidepressant activity. In the CNS the antinociceptive activity of this agent may involve high affinity binding to and inhibition of N-methyl-D-aspartate (NMDA) receptors and/or the enhancement of the action of serotonin at the spinal terminals of an opioid-mediated intrinsic analgesia system. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C28819" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C28819" NCI Thesaurus) |
|
| ID |
http://purl.bioontology.org/ontology/PDQ/CDR0000614649 |
|
| CAS Registry |
549-18-8 |
|
| cui |
C0700523 |
|
| DATE FIRST PUBLISHED |
2008-09-10 |
|
| Date last modified |
2008-09-10 |
|
| definition |
The hydrochloride salt of the tricyclic dibenzocycloheptadiene amitriptyline with antidepressant and antinociceptive activities. Amitriptyline inhibits the re-uptake of norepinephrine and serotonin by the presynaptic neuronal membrane in the central nervous system (CNS), thereby increasing the synaptic concentration of norepinephrine and serotonin. Due to constant stimulation to these receptors, amitriptyline may produce a downregulation of adrenergic and serotonin receptors, which may contribute to the antidepressant activity. In the CNS the antinociceptive activity of this agent may involve high affinity binding to and inhibition of N-methyl-D-aspartate (NMDA) receptors and/or the enhancement of the action of serotonin at the spinal terminals of an opioid-mediated intrinsic analgesia system. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C28819" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C28819" NCI Thesaurus) |
|
| NCI ID |
C28819 |
|
| notation |
CDR0000614649 |
|
| NSC Code |
104210 169910 |
|
| ORIG STY |
Drug/agent |
|
| prefLabel |
amitriptyline hydrochloride |
|
| tui |
T109 T121 |